Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Don’t Worry, GE Stock Has Plenty of Positive Catalysts Ahead

By Chris Lau, InvestorPlace Contributor

GE already wrote down much of the costs of the Boeing 737 Max delays last quarter, and there's plenty to lift GE stock in 2020.

Record iPhone Sales Could Send Apple Stock to New Highs

By Chris Lau, InvestorPlace Contributor

Apple wooed investors with its strong services revenue growth but strong momentum in iPhone 11 could get Apple stock to new highs.

Why Roku Stock Could Fly Higher After the Holiday Season

By Chris Lau, InvestorPlace Contributor

A recent stock offering and a "double top" sent ROKU stock lower. But that downtrend could end fast. Here's why.

7 Stocks to Buy to Get 2020 Started the Right Way

By Chris Lau, InvestorPlace Contributor

With stocks priced in for sustained growth ahead, what are the seven stocks to buy before 2020?

2 Positive Catalysts For Amazon Heading into 2020

By Chris Lau, InvestorPlace Contributor

Amazon did not move by much in the last five months. But, that standstill will end as the company’s positive catalysts unlock and growth accelerates.

Why a Bump in Vehicle Sales Could Accelerate Nio Stock

By Chris Lau, InvestorPlace Contributor

A US/China trade deal removes uncertainties for Nio but a sales acceleration is what will lift the stock higher.

Teladoc Stock Is Poised for More Explosive Growth Ahead

By Chris Lau, InvestorPlace Contributor

Teladoc stock will soar in 2020 as it adds new users and expands its international reach. It's a great stock to buy in the new year.

For Penny Investors, Ocugen Stock Makes a Good Speculative Play

By Chris Lau, InvestorPlace Contributor

With two orphan drug designations and a promising partnership, Ocugen stock makes a good play for speculative investors.

5 Undervalued Stocks to Buy

By Chris Lau, InvestorPlace Contributor

These undervalued stocks have been hit hard lately, but they still have what it takes to make a comeback, making them solid stocks to buy.

Okta Stock Will Not Disappoint Investors, Even if There’s Profit-Taking

By Chris Lau, InvestorPlace Contributor

Okta fulfilled a business need of security management, where its demand just keeps growing.

Load More